Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 57207434135

Countries

Japan, United States

Activities

Collapse all

Employment (4)

Century Therapeutics LLC: Philadelphia, PA, US

2019-12-01 to present | Scientific Expert
Employment
Source: Self-asserted source
Toshinobu Nishimura

Stanford University School of Medicine: Stanford, CA, US

2019-02-16 to 2019-11-30 | Basic Life Research Scientist (Institute for Stem Cell Biology and Regenerative Medicine)
Employment
Source: Self-asserted source
Toshinobu Nishimura

Stanford University School of Medicine: Stanford, CA, US

2014-02-16 to 2019-02-15 | Postdoctoral Researcher (Institute for Stem Cell Biology and Regenerative Medicine)
Employment
Source: Self-asserted source
Toshinobu Nishimura

The University of Tokyo: Tokyo, JP

2012-04-01 to 2014-02-15 | Research Scientist (Institute of Medical Science)
Employment
Source: Self-asserted source
Toshinobu Nishimura

Education and qualifications (2)

The University of Tokyo: Tokyo, JP

2007-04-01 to 2012-12-12 | Ph.D. (Life Science)
Education
Source: Self-asserted source
Toshinobu Nishimura

The University of Tokyo: Tokyo, JP

2003-04-01 to 2007-03-31 | B.S.
Education
Source: Self-asserted source
Toshinobu Nishimura

Works (21)

Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors

Nature Biotechnology
2025-02 | Journal article
DOI: 10.1038/s41587-024-02171-w
Contributors: Fabian P. Suchy; Daiki Karigane; Yusuke Nakauchi; Maimi Higuchi; Jinyu Zhang; Katja Pekrun; Ian Hsu; Amy C. Fan; Toshinobu Nishimura; Carsten T. Charlesworth et al.
Source: check_circle
Crossref

Development of iPSC-Derived T Cells Targeting EGFR Neoantigens in Non-Small Cell Lung Cancer

2025-02-20 | Preprint
DOI: 10.1101/2025.02.15.638388
Contributors: Kouta Niizuma; Toshinobu Nishimura; Jonathan Villanueva; Laura Amaya; Jonas L. Fowler; Taichi Isobe; Yusuke Nakauchi; Brandon Saavedra; Haojun Xu; Mahito Nakanishi et al.
Source: check_circle
Crossref

Sufficiency for inducible Caspase-9 safety switch in human pluripotent stem cells and disease cells.

Gene therapy
2020-07-23 | Journal article
DOI: 10.1038/s41434-020-0179-z
PMID: 32704085
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 2)‎

Diamond Blackfan anemia is mediated by hyperactive Nemo-like kinase.

Nature communications
2020-07-03 | Journal article
DOI: 10.1038/s41467-020-17100-z
PMID: 32620751
PMC: PMC7334220
Source: Self-asserted source
Toshinobu Nishimura

Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards.

Nature communications
2020-06-01 | Journal article
DOI: 10.1038/s41467-020-16455-7
PMID: 32483127
PMC: PMC7264334
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 3)‎

Use of polyvinyl alcohol for chimeric antigen receptor T-cell expansion.

Experimental hematology
2019-12-23 | Journal article
DOI: 10.1016/j.exphem.2019.11.007
PMID: 31874780
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 2)‎

Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination.

Cell stem cell
2019-05-01 | Journal article
DOI: 10.1016/j.stem.2019.04.001
PMID: 31051134
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 2)‎

Generation of Antigen-Specific T Cells from Human Induced Pluripotent Stem Cells.

Methods in molecular biology (Clifton, N.J.)
2019-01-01 | Journal article
DOI: 10.1007/978-1-4939-8938-6_3
PMID: 30649763
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 2)‎

Human iPSC Generation from Antigen-Specific T Cells.

Methods in molecular biology (Clifton, N.J.)
2019-01-01 | Journal article
DOI: 10.1007/978-1-4939-9728-2_5
PMID: 31396928
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 2)‎

Using the Inducible Caspase-9 Suicide-Safeguard System with iPSC and Bioluminescent Tracking.

Methods in molecular biology (Clifton, N.J.)
2019-01-01 | Journal article
DOI: 10.1007/978-1-4939-9728-2_20
PMID: 31396943
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 2)‎

Efficient scarless genome editing in human pluripotent stem cells.

Nature methods
2018-11-30 | Journal article
DOI: 10.1038/s41592-018-0212-y
PMID: 30504872
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 2)‎

Thalidomide induces apoptosis in undifferentiated human induced pluripotent stem cells.

In vitro cellular & developmental biology. Animal
2017-08-28 | Journal article
DOI: 10.1007/s11626-017-0192-8
PMID: 28849348
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 2)‎

Functional Analysis of Dendritic Cells Generated from T-iPSCs from CD4+ T Cell Clones of Sjögren's Syndrome.

Stem cell reports
2017-05-01 | Journal article
DOI: 10.1016/j.stemcr.2017.04.010
PMID: 28494936
PMC: PMC5425788
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 2)‎

An All-Recombinant Protein-Based Culture System Specifically Identifies Hematopoietic Stem Cell Maintenance Factors.

Stem cell reports
2017-02-23 | Journal article
DOI: 10.1016/j.stemcr.2017.01.015
PMID: 28238792
PMC: PMC5355634
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 2)‎

Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease.

Cell stem cell
2017-01-12 | Journal article
DOI: 10.1016/j.stem.2016.11.018
PMID: 28089908
PMC: PMC5508733
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 2)‎

Inhibition of Apoptosis Overcomes Stage-Related Compatibility Barriers to Chimera Formation in Mouse Embryos.

Cell stem cell
2016-11-01 | Journal article
DOI: 10.1016/j.stem.2016.10.013
PMID: 27814480
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 2)‎

A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy.

Stem cell reports
2015-08-28 | Journal article
DOI: 10.1016/j.stemcr.2015.07.011
PMID: 26321144
PMC: PMC4624898
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 2)‎

Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.

Leukemia
2014-04-15 | Journal article
DOI: 10.1038/leu.2014.136
PMID: 24732596
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 2)‎

Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation.

Cell stem cell
2013-01-01 | Journal article
DOI: 10.1016/j.stem.2012.11.002
PMID: 23290140
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 2)‎

Stepwise development of hematopoietic stem cells from embryonic stem cells.

PloS one
2009-03-16 | Journal article
DOI: 10.1371/journal.pone.0004820
PMID: 19287487
PMC: PMC2653650
Source: Self-asserted source
Toshinobu Nishimura
grade
Preferred source (of 2)‎

Antigen-receptor genes of the agnathan lamprey are assembled by a process involving copy choice

Nature Immunology
2007 | Journal article
DOI: 10.1038/ni1419
EID:

2-s2.0-33846481302

Part of ISBN:

15292908 15292916
Contributors: Nagawa, F.; Kishishita, N.; Shimizu, K.; Hirose, S.; Miyoshi, M.; Nezu, J.; Nishimura, T.; Nishizumi, H.; Takahashi, Y.; Hashimoto, S.-I. et al.
Source: Self-asserted source
Toshinobu Nishimura via Scopus - Elsevier

Peer review (1 review for 1 publication/grant)

Review activity for World journal of surgical oncology (1)
How many people are using ORCID?